Related Experiment Video
Updated: Feb 16, 2026
06:46
Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
Published on: September 27, 2024
937
Statin consumption as a risk factor for developing colorectal cancer: a retrospective case study
David Renman1, Erik Lundberg2, Ulf Gunnarsson2
1Institution of Surgery and Perioperative Science, Umeå University, 90185, Umeå, Sweden. dare0018@student.umu.se.
World Journal of Surgical Oncology
|December 17, 2017
Summary
This study found no increased risk of colorectal cancer in patients taking statins. Statin use was not linked to cancer-specific survival rates in diagnosed patients.
Area of Science:
- Oncology
- Pharmacology
- Epidemiology
Background:
- Statins are widely prescribed lipid-lowering drugs, particularly in elderly populations.
- Colorectal cancer is a common malignancy with a median age of diagnosis at 72 years.
- Statins may potentially increase cancer risk by inducing mitochondrial damage and reactive oxygen species.
Purpose of the Study:
- To investigate the association between statin use and the risk of developing colorectal cancer.
- To examine the impact of statin use on cancer-specific survival in colorectal cancer patients.
Main Methods:
- A case study of 325 colorectal cancer patients diagnosed between 2012-2015 at Norrlands University Hospital.
- Exclusion of type II diabetics for primary endpoint analysis; age-matched population data used for comparison.
- Secondary analysis assessed cancer-specific survival based on 'recent' statin use at diagnosis.
Main Results:
- Statin use was similar in colorectal cancer patients (23.8%) and the age-matched general population (24.6%), showing no significant difference.
- A trend towards increased recent statin use was observed in younger age groups (20-64 years) within the study population (17.8% vs. 11.9%).
- No significant difference in cancer-specific survival was found between 'recent' statin users and 'former/never' users.
Conclusions:
- Statin therapy does not appear to significantly increase the risk of developing colorectal cancer.
- Recent statin use at the time of colorectal cancer diagnosis did not correlate with altered cancer-specific survival.
Related Concept Videos
01:20Lipid-Lowering Drugs: Statins and Miscellaneous Agents
1.5K
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.5K
02:59Cancer Prevention
8.2K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
8.2K
01:11Observational Studies
11.2K
Observational studies are a type of analytical study where researchers observe events without any interventions. In other words, the researcher does not influence the response variable or the experiment's outcome.
There are three types of observational studies – Prospective, retrospective, and cross-sectional.
Prospective Study
Prospective studies, also known as longitudinal or cohort studies, are carried out by collecting future data from groups sharing similar characteristics. One...
There are three types of observational studies – Prospective, retrospective, and cross-sectional.
Prospective Study
Prospective studies, also known as longitudinal or cohort studies, are carried out by collecting future data from groups sharing similar characteristics. One...
11.2K
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
488
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
488
01:26Atherosclerosis III: Management
459
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
459